Easy Trip Planners Limited (BOM:543272)
9.83
+0.01 (0.10%)
At close: Aug 1, 2025
Intra-Cellular Therapies Revenue
In the fiscal year ending March 31, 2025, Easy Trip Planners had annual revenue of 5.87B INR, down -0.55%. Easy Trip Planners had revenue of 1.39B in the quarter ending March 31, 2025, a decrease of -14.97%.
Revenue
5.87B
Revenue Growth
-0.55%
P/S Ratio
5.98
Revenue / Employee
7.80M
Employees
753
Market Cap
35.13B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 5.87B | -32.52M | -0.55% |
Mar 31, 2024 | 5.91B | 1.42B | 31.58% |
Mar 31, 2023 | 4.49B | 2.13B | 90.69% |
Mar 31, 2022 | 2.35B | 968.71M | 69.94% |
Mar 31, 2021 | 1.39B | -28.57M | -2.02% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,765.41B |
HDFC Bank | 2,736.06B |
Bharti Airtel | 1,729.85B |
Tata Consultancy Services | 2,561.48B |
ICICI Bank | 2,054.85B |
State Bank of India | 3,429.39B |
Infosys | 1,672.76B |
Hindustan Unilever | 638.72B |